• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, January 10, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Mining microbial treasures from toxic sites

Bioengineer by Bioengineer
May 8, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Filled with a noxious brew of copper, cadmium and arsenic, with a pH rivaling that of sulfuric acid, Montana’s Berkeley Pit seems inhospitable to life. Nonetheless, scientists have discovered microorganisms in this abandoned copper mine and other human-made noxious sites. These extreme environments induce microbes to synthesize potent, never-before-seen molecules that could find uses in human medicine, according to an article in Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society.

Recently, scientists have begun exploring places like old copper mines and smoldering coal seams for signs of life. They suspect that some of the unusual molecules that microbes make to stay alive under such hostile conditions could help humans survive maladies such as cancer or antibiotic-resistant bacterial infections. However, researchers face substantial challenges in growing these microorganisms in the lab and isolating potentially useful compounds, which are just the first of many steps to move drugs into the clinic, freelance contributor Carrie Arnold writes.

Replicating in the lab the extreme environments in which these microbes thrive can be challenging or impossible. However, researchers Andrea and Don Stierle at the University of Montana cultured fungi from the Berkeley Pit in a nutrient broth spiked with pit water. The Stierles have since extracted and purified several new molecules from the fungi that show anti-cancer and antibiotic activities in vitro. Because many such extremophiles can’t be grown in the lab, some researchers have turned to a technique called metagenomics, which involves sequencing microbial DNA directly from environmental samples and then predicting classes of molecules the microbes might be making. Although no compounds identified from noxious environments have yet made it into the clinic, experts predict that it’s only a matter of time before these manmade disasters yield lifesaving medicines.

###

The article, “Scientists mine for potential drugs in the Berkeley Pit and other industrial sites,” is freely available here.

The American Chemical Society, the world’s largest scientific society, is a not-for-profit organization chartered by the U.S. Congress. ACS is a global leader in providing access to chemistry-related information and research through its multiple databases, peer-reviewed journals and scientific conferences. ACS does not conduct research, but publishes and publicizes peer-reviewed scientific studies. Its main offices are in Washington, D.C., and Columbus, Ohio.

To automatically receive news releases from the American Chemical Society, contact [email protected].

Follow us on Twitter | Facebook

Media Contact
Katie Cottingham
[email protected]
https://cen.acs.org/biological-chemistry/natural-products/Scientists-mine-potential-drugs-Berkeley/97/i18

Tags: BiochemistryBiodiversityChemistry/Physics/Materials SciencesMicrobiologyPharmaceutical SciencePharmaceutical Sciences
Share12Tweet8Share2ShareShareShare2

Related Posts

Nanoagent Targets HER2 for Cancer Antibody Delivery

January 10, 2026

Pharmacist-Led Deprescribing Boosts Outcomes for Seniors

January 10, 2026

Tackling Non-Communicable Diseases in Rural Bangladesh’s Clinics

January 10, 2026

MSLN Activates EGFR-ERK1/2 to Drive Liver Metastasis

January 10, 2026
Please login to join discussion

POPULAR NEWS

  • Enhancing Spiritual Care Education in Nursing Programs

    154 shares
    Share 62 Tweet 39
  • PTSD, Depression, Anxiety in Childhood Cancer Survivors, Parents

    145 shares
    Share 58 Tweet 36
  • Impact of Vegan Diet and Resistance Exercise on Muscle Volume

    46 shares
    Share 18 Tweet 12
  • SARS-CoV-2 Subvariants Affect Outcomes in Elderly Hip Fractures

    45 shares
    Share 18 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Nanoagent Targets HER2 for Cancer Antibody Delivery

Pharmacist-Led Deprescribing Boosts Outcomes for Seniors

Tackling Non-Communicable Diseases in Rural Bangladesh’s Clinics

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 71 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.